Inappropriate statistical method in a parallel-group randomized controlled trial results in unsubstantiated conclusions

por Dimova, Rositsa B., Allison, David B.
Publicado 2016

Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: Reports to the vaccine adverse event reporting system

por Woo, Emily Jane, Dimova, Rositsa B.
Publicado 2022

FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B

por Zeremski, Marija, Dimova, Rositsa B, Benjamin, Samantha, Makeyeva, Jessy, Yantiss, Rhonda K, Gambarin-Gelwan, Maya, Talal, Andrew H
Publicado 2014

Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022

por Woo, Emily Jane, Gee, Julianne, Marquez, Paige, Baggs, James, Abara, Winston E., McNeil, Michael M., Dimova, Rositsa B., Su, John R.
Publicado 2023